Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-052635
Filing Date
2026-08-04
Accepted
2026-08-04 16:30:21
Documents
103
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q - PCRX - 06.30.2026 pcrx-20260630.htm   iXBRL 10-Q 1741910
2 EX-2.1 pcrx-06302026xex21.htm EX-2.1 1002898
3 EX-10.1 ex101teehanexecutiveagreem.htm EX-10.1 105542
4 EX-31.1 pcrx-06302026xex311.htm EX-31.1 11724
5 EX-31.2 pcrx-06302026xex312.htm EX-31.2 11699
6 EX-32.1 pcrx-06302026xex321.htm EX-32.1 8309
12 PACIRA BIOSCIENCES LOGO pcrx-20260630_g1.jpg GRAPHIC 468777
13 PRODUCT PIPELINE pcrx-20260630_g2.gif GRAPHIC 218330
  Complete submission text file 0001628280-26-052635.txt   13615404

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20260630.xsd EX-101.SCH 70713
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20260630_cal.xml EX-101.CAL 93668
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20260630_def.xml EX-101.DEF 476625
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20260630_lab.xml EX-101.LAB 913381
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20260630_pre.xml EX-101.PRE 694095
107 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20260630_htm.xml XML 1519522
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 261239260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)